Magnasense
Founded in Finland in 2003, Magnasense specializes in developing and manufacturing lateral flow tests for various applications. These include human health, environmental analysis, and veterinary testing. The company's innovative magnetic labeling technique enables quantitative measurements, enhancing reliability and sensitivity. Magnasense offers a Pilot Feasibility test service and operates as a subsidiary of LifeAssays AB.
Top Regions
Top Stages
1 past transactions
Viraspec
Acquisition in 2020
Viraspec AB is a diagnostics company based in Lund, Sweden, founded in 2020. It specializes in the development and commercialization of rapid diagnostic tests for COVID-19. The company focuses on point-of-care testing, utilizing a robust platform that analyzes blood and saliva samples for the presence of antibodies and the virus itself. Viraspec's innovative test device includes a blood collector and an indicator, facilitating the collection of samples and providing results directly on the device. This approach enables patients to obtain faster, more accurate, and cost-effective diagnostic results, thereby enhancing the fight against COVID-19. As of September 2020, Viraspec operates as a subsidiary of AegirBio AB.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.